The role of activation-induced cytidine deaminase in lymphomagenesis

Current Opinion in Hematology

Volumn 19, Issue 4, 2012, Pages 292-298

  Gu, Xiwen ^a   Shivarov, Velizar ^a   Strout, Matthew P ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

activation induced cytidine deaminase; chromosome translocations; class switch recombination; lymphoma; somatic hypermutation

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; DOUBLE STRANDED DNA;

B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME; CHROMOSOME TRANSLOCATION; DISEASE COURSE; DOUBLE STRANDED DNA BREAK; ENZYME BINDING; GENETIC ASSOCIATION; GENETIC RECOMBINATION; GENOME; HUMAN; LYMPHOMAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SOMATIC HYPERMUTATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYTIDINE DEAMINASE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOMA, B-CELL; MICE; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSLOCATION, GENETIC;

EID: 84862123066     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328353da3a     Document Type: Review

References (52)

1. Muramatsu M, Kinoshita K, Fagarasan S, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102:553-563.
2. Stavnezer J. Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol 2011; 32:194-201.
3. Bothmer A, Robbiani DF, Feldhahn N, et al. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J Exp Med 2010; 207:855-865.
4. Vuong BQ, Lee M, Kabir S, et al. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat Immunol 2009; 10:420-426.
5. Pavri R, Gazumyan A, Jankovic M, et al. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 2010; 143:122-133.
6. Nowak U, Matthews AJ, Zheng S, et al. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat Immunol 2010; 12:160-166.
7. Conticello SG, Ganesh K, Xue K, et al. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Mol Cell 2008; 31:474-484.
8. Kanehiro Y, Todo K, Negishi M, et al. Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1. Proc Natl Acad Sci USA 2012; 109:1216-1221.
9. Maeda K, Singh SK, Eda K, et al. GANP-mediated recruitment of activationinduced cytidine deaminase to cell nuclei and to immunoglobulin variable region DNA. J Biol Chem 2010; 285:23945-23953.
10. Basu U, Meng F-L, Keim C, et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 2011; 144:353-363.
11. Pham P, Calabrese P, Park SJ, et al. Analysis of a single-stranded DNAscanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversity. J Biol Chem 2011; 286:24931-24942.
12. Han L, Masani S, Yu K. Overlapping activation-induced cytidine deaminase hotspot motifs in Ig class-switch recombination. Proc Natl Acad Sci USA 2011; 108:11584-11589.
13. Han JH, Akira S, Calame K, et al. Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Immunity 2007; 27:64-75. (Pubitemid 47089025)
14. Popp C, Dean W, Feng S, et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 2010; 463:1101-1105.
15. Pasqualucci L, Guglielmino R, Houldsworth J, et al. Expression of the AID protein in normal and neoplastic B cells. Blood 2004; 104:3318-3325. (Pubitemid 39507152)
16. Tran TH, Nakata M, Suzuki K, et al. B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat Immunol 2010; 11:148-154.
17. Teng G, Hakimpour P, Landgraf P, et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008; 28:621-629.
18. de Yebenes VG, Belver L, Pisano DG, et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med 2008; 205:2199-2206.
19. Patenaude AM, Orthwein A, Hu Y, et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 2009; 16:517-527.
20. Aoufouchi S, Faili A, Zober C, et al. Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med 2008; 205:1357-1368. (Pubitemid 351831492)
21. Lossos IS, Levy R, Alizadeh AA. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 2004; 18:1775-1779. (Pubitemid 39530006)
22. Lenz G, Nagel I, Siebert R, et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 2007; 204:633-643. (Pubitemid 46457085)
23. Shikata H, Yakushijin Y, Matsushita N, et al. Role of activation-induced cytidine deaminase in the progression of follicular lymphoma. Cancer Sci 2011; 103:415-421.
24. Deutsch AJ, Aigelsreiter A, Staber PB, et al. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation. Blood 2007; 109:3500-3504. (Pubitemid 46572541)
25. Palacios F, Moreno P, Morande P, et al. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. Blood 2010; 115:4488-4496.
26. Oppezzo P, Vuillier F, Vasconcelos Y, et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 2003; 101:4029-4032. (Pubitemid 36857882)
27. Koduru S, Wong E, Strowig T, et al. Dendritic cell-mediated activationinduced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma. Blood 2012; 119:2302-2309.
28. Liu M, Duke JL, Richter DJ, et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008; 451:841-845. (Pubitemid 351253166)
29. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412:341-346. (Pubitemid 32691848)
30. Mottok A, Renne C, Seifert M, et al. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood 2009; 114:4503-4506.
31. Cattoretti G, Mandelbaum J, Lee N, et al. Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer Res 2009; 69:8686-8692.
32. Schuetz JM, Johnson NA, Morin RD, et al. BCL2 mutations in diffuse large B-cell lymphoma. Leukemia 2012. [Epub ahead of print]
33. Pasqualucci L, Migliazza A, Basso K, et al. Mutations of the BCL6 protooncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003; 101:2914-2923. (Pubitemid 36857975)
34. Gagyi E, Balogh Z, Bodor C, et al. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression. Haematologica 2008; 93:1822-1828.
35. Reiniger L, Bodor C, Bognar A, et al. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia 2006; 20:1089-1095. (Pubitemid 43797302)
36. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43:830-837.
37. Yamane A, Resch W, Kuo N, et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol 2011; 12:62-69.
38. Lohr JG, Stojanov P, Lawrence MS, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109:3879-3884.
39. Ramiro AR, Jankovic M, Eisenreich T, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004; 118:431-438. (Pubitemid 39485663)
40. Robbiani DF, Bothmer A, Callen E, et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008; 135:1028-1038.
41. Robbiani DF, Bunting S, Feldhahn N, et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell 2009; 36:631-641.
42. Hasham MG, Donghia NM, Coffey E, et al. Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat Immunol 2010; 11:820-826.
43. Jankovic M, Robbiani DF, Dorsett Y, et al. Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proc Natl Acad Sci USA 2010; 107:187-192.
44. Staszewski O, Baker RE, Ucher AJ, et al. Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig loci in activated B cells. Mol Cell 2011; 41:232-242.
45. Kato L, Begum NA, Burroughs AM, et al. Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes. Proc Natl Acad Sci USA 2012; 109:2479-2484.
46. Chiarle R, Zhang Y, Frock RL, et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 2011; 147:107-119.
47. Klein IA, Resch W, Jankovic M, et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 2011; 147:95-106.
48. Hakim O, Resch W, Yamane A, et al. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 2012. [Epub ahead of print]
49. Kotani A, Kakazu N, Tsuruyama T, et al. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice. Proc Natl Acad Sci USA 2007; 104:1616-1620. (Pubitemid 46214639)
50. Nepal RM, Zaheen A, Basit W, et al. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice. Oncogene 2008; 27:4752-4756.
51. Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Gen 2008; 40:108-112.
52. Bhutani N, Brady JJ, Damian M, et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010; 463:1042-1047.